본문 바로가기
KERD
논문KCI 등재

Piperacillin/Tazobactam 사용이 ESBL 생산균의 장집락에 미치는 영향

Impact of Piperacillin/Tazobactam Use to Intestinal Colonization of Extended- spectrum-lactamase Producing Escherichia coli and Klebsiella pneumoniae

1

조회

0

다운로드

0

인용

0

참고문헌

주제분류내과학

참고문헌 (29)

  1. Eisenstein BI, "Enterobacteriaceae" (2000), Philadelpia Chur Living
  2. Tenover FC, "Detection and reporting of organisms producing extended-spectrum beta-lactamases survey of laboratories in Connecticut", 37, pp.4065~4070 (1999)
  3. Fridkin SK, "Antimicrobial resistance in intensive care units", 20, pp.303~316 (1999)
  4. Pfaller MA, "Survey of blood stream infections due to gram-negative bacilli", 29, pp.595~607 (1997)
  5. Pai H, "Surevey of extended-spectru beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae", 37, pp.1758~1763 (1999)
  6. Meyer KS, "Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins", pp.353~8 (1993)
  7. Lee KW, "Korean Nationwide Surveillance Of Antimicrobial Resistance Group : Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and extended-spectru cephalosporin and imipenem resistance in gram-negative bacilli", 44, pp.571~578 (2003)
  8. Kim BN, "Clinical implications of extended-spectru beta-lactamase-producing Klebsiella pneumoniae bacteremia", 52, pp.99~106 (2002)
  9. Lautenbach E, "Epidemiological investigation of fluoroquinolone resistance in Infections due to Extended-spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae", 33, pp.1288~1294 (2001)
  10. Bisson G, "Extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella species, risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence", 23, pp.254~260 (2002)
  11. Kim YK, "Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia Extended-spectrum β-lactamases 291 coli and Klebsiella pneumoniae in children, epidemiology and clinical outcome", 46, pp.1481~1491 (2002)
  12. Menashe G, "Clinical significance and impact on mortality of extended- spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia", 33, pp.188~193 (2001)
  13. Lucet JC, "Outbreak of multiply resistant enterobacteriaceae in an intensive care unit epidemiology and risk factors for acquisition", 22, pp.430~436 (1996)
  14. Ho PL, "Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase a case-control study of risk factors and outcomes", 34, pp.567~573 (2002)
  15. Jan E Patterson, "Association of antibiotic utilization measures and control of multiple drug resistance in Klebsiella pneumoniae", 21, pp.455~458 (2000)
  16. Pai HJ, "Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC type β-Lactamase-Producing Klebsiella pneumoniae", 48, pp.3720~3728 (2004)
  17. CDC NNIS system, "National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2003, Issued August 2003", 31, pp.481~498 (2003)
  18. Horan TC, "Definitions of key terms used int the NNIS system", 25, pp.112~116 (1997)
  19. "NNIS manual 2002", pp.1156~1157 (2002)
  20. Livermore DM, "β-lactamases in laboratory and clinical resistance", 8, pp.557~584 (1995)
  21. Song WG, "Extended-spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae isolates from 12 hospital in Korea", 18, pp.401~410 (2000)
  22. Kim YT, "TEM, SHV and CTX-M from Clinical Isolates of Klebsiella pneumoniae and Comparison with Antibiotic Susceptibility Test Characterization of Extended-Spectrum-β-Lactamase Genotype", 11, pp.389~396 (2005)
  23. Kollef MH, "Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?", 9, pp.82~88 (2006)
  24. Koulenti D, "Hospital-acquired pneumonia in the 21st century a review of existing treatment options and their impact on patient care", 8(7), pp.1555~1569 (2006)
  25. Wyllie DH, "Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study", 333(281) (2006)
  26. Garner JS, "Guideline for isolation precautions in hospitals; The Hospital Infection Control Practices Advisory Committee", 17, pp.53~80 (1996)
  27. Ho PL, "Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase a case-control study of risk factors and outcomes", 34, pp.567~573 (2002)
  28. Rice LB, "Ceftazidime resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center", 23, pp.118~124 (1996)
  29. Patterson JE, "Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae", 21, pp.455~458 (2000)

관련 논문AI추천

광범위베타락탐아제 생성 Escherichia coli와 Klebsiellapneumoniae의 piperacillin/tazobactam에 대한 시험관내 감수성김의종대한감염학회 · Infection and Chemotherapy2008 · 제40권 제1호Non-carbapenem Drugs for Patients with Bacteremia caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Piperacillin-Tazobactam김미선, 오현주, 유정래, 이승희, 허상택대한내과학회 · 대한내과학회지2024 · 제99권 제3호광범위 베타 락탑계 항생제 분해효소를 생성하는 폐렴간균에 의한 균혈증이 발생한 환자에서 감염의 위험 인자 및 치료 결과강철인, 김성한, 김의종, 김홍빈, 박상원, 방지환, 오명돈, 최강원, 최영주대한감염학회 · Infection and Chemotherapy2003 · 제35권 제2호5년동안 혈액에서 배양된 Escherichia coli와 Klebsiella pneumoniae의 항균제 감수성 : Extended-Spectrum b-Lactamase 생성 균주의 영향강철인, 김동민, 김의종, 김홍빈, 박완범, 오명돈, 이기덕, 이종윤, 최강원대한감염학회 · Infection and Chemotherapy2003 · 제35권 제6호Prepenem과 Carbapenem 항생제의 몇 가지 임상균주에 대한 시험관내 항균력 비교강문원, 강진한, 김명신, 김상일, 송민진, 신완식, 위성헌, 유진홍, 이동건, 전혜선, 최수미, 최정현대한감염학회 · Infection and Chemotherapy2003 · 제35권 제6호Panipenem을 포함한 Carbapenem 계열 항생제의 및 가지 임상균주에 대한 시험관내 항균력강문원, 강진한, 김명신, 김상일, 신완식, 위성헌, 유진홍, 이동건, 전혜선, 최수미, 최정현대한감염학회 · Infection and Chemotherapy2003 · 제35권 제2호

이 간행물의 다른 논문 (8건)